Creative Biolabs, a leading biotechnology CRO, has expanded its complement therapeutics and macrophage research solutions to support advanced immunology studies.

SHIRLEY, NY, May 22, 2026 /24-7PressRelease/ -- Innate immunity plays a central role in immune surveillance, inflammation regulation, and disease progression. Among innate immune pathways, the complement system and macrophage-mediated immune responses have become major targets in next-generation immunotherapy and precision medicine research.

Complement activation is closely associated with autoimmune disorders, chronic inflammation, neurodegenerative diseases, and tumor immune evasion. At the same time, macrophage polarization and tumor-associated macrophages (TAMs) are increasingly recognized as critical regulators of the tumor microenvironment.

To address the growing demand in innate immunity drug discovery, Creative Biolabs now offers integrated solutions for:
• Complement biomarker detection
• Complement-targeted aptamer development
• Macrophage polarization studies
• Macrophage functional assays
• Macrophage cell lines

These research solutions help pharmaceutical companies and academic institutions accelerate biomarker discovery, target validation, and immunotherapy development.

"By expanding our complement therapeutics and macrophage research capabilities, we aim to provide researchers with highly specialized tools for innate immunity drug discovery," said the chief scientist at Creative Biolabs.

High-Sensitivity Complement System Assay Kits
Accurate monitoring of complement activation is essential for preclinical and clinical development. Creative Biolabs provides a broad range of complement assay kits for high-sensitivity detection of components, activation fragments, and regulatory biomarkers across multiple pathways. These solutions support applications such as deficiency analysis, efficacy monitoring, and drug candidate screening, all optimized for translational immunology workflows.

Advanced Aptamer Development for Complement-Targeted Therapies
Aptamer-based therapeutics are gaining attention for their high specificity and superior tissue penetration compared to traditional antibodies. Leveraging its proprietary SELEX technology, Creative Biolabs provides custom aptamer development targeting complement proteins. These solutions include high-affinity screening, affinity maturation, and functional inhibition studies to support drug discovery for chronic inflammatory and autoimmune disorders.

Advanced Macrophage Products for Research and Therapeutic Development
Creative Biolabs offers a comprehensive portfolio of high-quality macrophage products designed to support macrophage biology studies, disease modeling, immunotherapy development, and translational research applications. Our product solutions include, but are not limited to:
• Primary macrophages from multiple species and tissue sources
• M0, M1, and M2 polarized macrophages
• Bone marrow-derived, peripheral blood-derived, alveolar, and peritoneal macrophages
• Customized macrophage products tailored to specific research needs

"Our macrophage products are available from human, mouse, canine, hamster, and non-human primate sources, enabling researchers to establish physiologically relevant in vitro and in vivo models for immune response evaluation and therapeutic development," said a scientist.

Partner with Creative Biolabs to accelerate your next-generation innate immunity drug discovery by visiting https://www.creative-biolabs.com/complement-therapeutics/.

About Creative Biolabs
Creative Biolabs is a global biotechnology company specializing in immunology with a strong emphasis on complement‑based therapeutic research. Leveraging deep expertise in the complement system, the company provides tailored CRO services that support the development of next‑generation complement‑targeted drugs, from mechanism exploration and target validation to functional assays and translational studies.

Read the full story here: https://www.24-7pressrelease.com/press-release/535115/creative-biolabs-expands-complement-therapeutics-and-macrophage-research-solutions-for-advanced-immunotherapy

Press Release Service and Press Release Distribution by 24-7 Press Release Newswire